Literature DB >> 9262867

Beta-adrenoceptors in the tree shrew brain. I. Distribution and characterization of [125I]iodocyanopindolol binding sites.

G Flügge1, O Ahrens, E Fuchs.   

Abstract

1. The number and distribution pattern of beta-adrenergic receptors in the brain have been reported to be species specific. The aim of the present study was to describe binding of the beta-adrenoceptor ligand [125I]iodocyanopindolol in the brain of the tree shrew (Tupaia belangeri), a species which provides an appropriate model for studies of psychosocial stress and its consequences on central nervous processes. 2. 125I-Iodocyanopindolol (125ICYP) labeling revealed a high degree of nonspecific binding, which was due mainly to interactions of this ligand with serotonin binding sites. For a quantitative evaluation of beta 1- and beta 2-adrenoceptors, serotonin binding sites had to be blocked by 100 microM 5HT. 3. Binding of the radioligand to beta 1- and beta 2-adrenoceptors was characterized using the beta 1-specific antagonist CGP20712A and the beta 2-specific antagonist ICI118.551. beta 1-adrenoceptor binding is present in the whole brain, revealing low receptor numbers in most brain regions (up to 1.5 to 2.7 fmol/mg). A slight enrichment was observed in cortical areas (lateral orbital cortex: 4.0 +/- 0.7 fmol/mg) and in the cerebellar molecular layer (8.7 +/- 1.0 fmol/mg). 4. Competition experiments demonstrated high- and low-affinity binding sites with considerable variations in Ki values for CGP20712A, showing that various affinity states of beta 1-adrenoceptors are present in the brain (Ki: 0.61 nM to 67.1 microM). In the hippocampus, only low-affinity beta 1-adrenoceptors were detected (Ki: 1.3 +/- 0.2 microM). Since it is known that 125ICYP labels not only membrane bound but also internalized beta-adrenoceptors, it can be assumed that the large population of the low-affinity sites represents internalized receptors which may be abundant due to a high sequestration rate. 5. High numbers of beta 2-adrenoceptors are present in only a few brain structures of tree shrews (external layer of the olfactory bulb, 15.8 +/- 2.0 fmol/mg; claustrum, 19.3 +/- 1.5 fmol/mg; anteroventral thalamic nucleus, 19.4 +/- 1.5 fmol/mg; cerebellar molecular layer, 55.0 +/- 4.3 fmol/mg). Also for this class of beta-adrenoceptors, high- and low-affinity binding sites for the beta 2-selective antagonist ICI118.551 were observed, indicating that 125ICYP labels membrane bound and internalized beta 2-adrenoceptors. Only in the cerebellar molecular layer was a high percentage of high-affinity beta 2-adrenoceptors detected (Ki for ICI118.551 was 1.8 +/- 0.3 nM for 90% of the receptors). 6. In conclusion, beta 1- and beta 2-adrenoceptor binding can be localized and quantified by in vitro receptor autoradiography in the brains of tree shrews when serotonergic binding sites are blocked. Modulatory effects of long-term psychosocial conflict on the central nervous beta-adrenoceptor system in male tree shrews are described in the following paper.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262867     DOI: 10.1023/a:1026335327150

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  40 in total

1.  The distribution of beta-1- and beta-2-adrenergic receptors of normal and reeler mouse brain: an in vitro autoradiographic study.

Authors:  D Lorton; J N Davis
Journal:  Neuroscience       Date:  1987-10       Impact factor: 3.590

2.  Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover.

Authors:  A M Thierry; F Javoy; J Glowinski; S S Kety
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

3.  Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization.

Authors:  S S Yu; R J Lefkowitz; W P Hausdorff
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

4.  Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human.

Authors:  P W Mantyh; S D Rogers; C J Allen; M D Catton; J R Ghilardi; L A Levin; J E Maggio; S R Vigna
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

5.  Beta-adrenergic receptor subtypes in stress-induced behavioral depression.

Authors:  S C Pandey; X Ren; J Sagen; G N Pandey
Journal:  Pharmacol Biochem Behav       Date:  1995 Jun-Jul       Impact factor: 3.533

Review 6.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

7.  Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain.

Authors:  T C Rainbow; B Parsons; B B Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Beta-adrenergic-receptor localization by light microscopic autoradiography.

Authors:  J M Palacios; M J Kuhar
Journal:  Science       Date:  1980-06-20       Impact factor: 47.728

9.  Species differences in the localization and number of CNS beta adrenergic receptors: rat versus guinea pig.

Authors:  R M Booze; E A Crisostomo; J N Davis
Journal:  J Pharmacol Exp Ther       Date:  1989-06       Impact factor: 4.030

10.  Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.

Authors:  U Gether; S Lin; B K Kobilka
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  2 in total

1.  Mitral cell beta1 and 5-HT2A receptor colocalization and cAMP coregulation: a new model of norepinephrine-induced learning in the olfactory bulb.

Authors:  Qi Yuan; Carolyn W Harley; John H McLean
Journal:  Learn Mem       Date:  2003 Jan-Feb       Impact factor: 2.460

2.  Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals.

Authors:  Brian P Ramos; Leslie A Colgan; Eric Nou; Amy F T Arnsten
Journal:  Neurobiol Aging       Date:  2007-03-23       Impact factor: 4.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.